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Background: Increasing experimental and clinical data indicate that early brain injury (EBI) after subarachnoid
hemorrhage (SAH) largely contributes to unfavorable outcomes, and it has been proved that EBI following SAH is
closely associated with oxidative stress and brain edema. The present study aimed to examine the effect of
hydrogen, a mild and selective cytotoxic oxygen radical scavenger, on oxidative stress injury, brain edema and
neurology outcome following experimental SAH in rabbits.
Results: The level of MDA, caspase-12/3 and brain water content increased significantly at 72 hours after
experimental SAH. Correspondingly, obvious brain injury was found in the SAH group by terminal deoxynucleotidyl
transferase-mediated uridine 5’-triphosphate-biotin nick end-labeling (TUNEL) and Nissl staining. Similar results were
found in the SAH+ saline group. In contrast, the upregulated level of MDA, caspase-12/3 and brain edema was
attenuated and the brain injury was substantially alleviated in the hydrogen treated rabbits, but the improvement of
neurology outcome was not obvious.
Conclusion: The results suggest that treatment with hydrogen in experimental SAH rabbits could alleviate brain
injury via decreasing the oxidative stress injury and brain edema. Hence, we conclude that hydrogen possesses the
potential to be a novel therapeutic agent for EBI after SAH.
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Subarachnoid hemorrhage (SAH), accounting for about
5-7% of all strokes, is a frequently seen devastating disease
with high mortality and disability [1]. After decades of stud-
ies both in basic and in clinic, considerable advances have
been made in diagnostic methods, endovascular techni-
ques, and surgical and medical therapy. Nonetheless, the
mortality and morbidity rates after spontaneous SAH have
not been decreased [2], the outcome of the patients with
SAH remains poor, with the mortality rate as high as 45%
and high morbidity among survivors [3,4]. As a result, there* Correspondence: sunxjk@hotmail.com; jxshi@yahoo.cn
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reproduction in any medium, provided the orhas been a consistent interest in understanding the molecu-
lar mechanisms responsible for SAH.
Two main issues have been focused following SAH: vaso-
spasm and early brain injury (EBI). It was thought that cere-
bral ischemia and other related complications, which result
in poor outcome, were more or less exclusively caused by
arterial narrowing after SAH. Hence, vasospasm has been
the focus of the majority of research efforts during the past
decades on SAH. Unfortunately, little success has been
achieved in improving outcome following SAH [5,6]. Espe-
cially, this idea has recently been challenged by the failure
of the drug clazosentan to improve patients’ outcome, des-
pite reversing vasoconstriction [6,7]. Therefore, we propose
to look beyond vasoconstriction, and consider more factors,
such as ischemia, disruption of the blood–brain barrier, ac-
tivation of apoptotic and inflammatory pathways, andl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Zhuang et al. BMC Neuroscience 2012, 13:47 Page 2 of 10
http://www.biomedcentral.com/1471-2202/13/47cortical spreading depression in the early stage following
SAH [8,9].
Increasing evidence has proved that the EBI period,
encompassing 24–72 hours following SAH, is closely bound
up with the poor prognosis [10,11]. Moreover, numerous
studies have demonstrated that oxidative stress and brain
edema are critical in the development of early brain injury
after SAH [12-14]. Among the complex factors involved in
the neuronal death after SAH, oxidative stress has been con-
sistently highlighted. Reactive oxygen species (ROS) or
reactive nitrogen species (RNS) (such as the hydroxyl radical
(•OH), superoxide anion (O-2•), hydrogen dioxide (H2O2), ni-
tric oxide (NO) and peroxynitrite (ONOO−)) have been
believed to play a critical role following SAH [15].
Brain edema has been proved to be a major component
of EBI as a direct consequence of the disruption of the
blood brain barrier (BBB) [16,17], rather than the result of
vasospasm [13]. In addition, global edema has been con-
sidered as an independent risk factor for mortality and
poor outcome after SAH [13]. It has been shown that ap-
proximately 8% of patients had global cerebral edema
detected by CT scan on admission, and approximately
additional 12% developed appreciable edema over the first
6 days [13]. Meanwhile, mounting evidence suggests that
oxidative stress injury is intimately associated with brain
edema [18].
Given the substantial evidence for significant levels of
oxidative stress and brain edema following SAH, the use of
free radical scavengers is a reasonable approach to improve
the prognosis. Hence, hydrogen (H2), which has been
gradually recognized as a potent anti-oxidative and anti-
apoptotic agent [19-21], may act as an effective therapeu-
tics after SAH. Many studies have evinced that H2 pos-
sesses cytoprotective effects in different cell types and
disease models, including ischemia-reperfusion injury [22],
drug toxicity [23] and trauma [24]. All these findings make
H2 a potential perfect candidate to provide protective ef-
fect for the brain after SAH. Hence, in this study, we used
an SAH model in rabbits to test whether H2 therapy could
ameliorate EBI following SAH.
Methods
Animal preparation
The experimental protocol of using animals was approved
by the Animal Care and Use Committee of Nanjing Univer-
sity and conformed to the Guide for the Care and Use of
Laboratory Animals from the National Institutes of Health.
All New Zealand white rabbits used in the present study
were purchased from Experimental Animal Central of Jinl-
ing Hospital (Nanjing, China). They were acclimated in a
humidified room and maintained on the standard pellet diet
at the Animal Center of Jinling Hospital for 10 days before
the experiment. The temperature in both the feeding room
and the operation room was maintained at about 25°C.Hydrogen-rich saline preparation
The hydrogen-rich saline was prepared as described previ-
ously [25]. Briefly, H2 was dissolved in normal saline for 2 h
under high pressure (0.4 MPa) to the supersaturated level
(more than 0.6 mmol/L) by using a self-designed hydrogen-
rich water-producing apparatus provided by the Department
of Diving Medicine, the Second Military Medical University,
China. The saturated hydrogen saline was stored under at-
mospheric pressure at 4°C in an aluminum bag with no
dead volume and was sterilized by gamma radiation.
Hydrogen-rich saline was freshly prepared every week to
ensure a constant concentration. Gas chromatography was
used to confirm the content of hydrogen in saline by the
method described by Ohsawa et al. [20].
Experimental design
Adult male New Zealand white rabbits weighing from 2.4
to 2.8 kg were assigned randomly to four groups: (1) con-
trol group (n=18), (2) SAH group (n=18), (3) SAH+ saline
group (n=18), and (4) SAH+hydrogen-rich saline group
(n =18). In the rabbits of SAH+hydrogen-rich saline
group, hydrogen-rich saline (5 ml/kg) [25] was adminis-
tered immediately after the first blood injection, which con-
tinued every 12 hours for 72 hours. Rabbits of SAH+ saline
group received equal volumes of saline at corresponding
time points. Both hydrogen-rich saline and saline were
injected intraperitoneally. Six rabbits in each group were
killed with the fixation perfusion method. The brains were
taken for Nissl staining, and TUNEL staining. The other
six rabbits in each group were exsanguinated and decol-
lated, with the brains removed and frozen in liquid nitrogen
immediately for biochemical studies. The rest of the six
were exsanguinated and decollated, and the brains were
used for brain water content measurement.
Two-hemorrhage rabbit model
Experimental SAH was produced according to the two-
hemorrhage method [26]. The rabbits were anesthetized
with an intramuscular injection of a mixture of ketamine
(25 mg/kg) and droperidol (1.0 mg/kg) on day 0. Under
spontaneous breathing, a 23-gauge butterfly needle was
inserted percutaneously into the cistern magna. Then about
1.5 ml nonheparinized fresh autologous auricular arterial
blood was slowly injected into the cisterna magna for 1 mi-
nute under aseptic technique. Then animals were kept in a
30° head-down position for 30 minutes. After recovery
from anesthesia, they were returned to the feeding room.
Forty-eight hours after the first SAH, the second injection
was performed in the same manner as the first.
Clinical evaluation
Clinical scores were recorded based on independent obser-
vations by a veterinarian who was blinded to the study. The
scores of animals sacrificed on day 3 were recorded daily
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previously [27].
Perfusion-fixation
The rabbits scheduled for death were anesthetized with an
intramuscular injection of a mixture of ketamine (40 mg/kg)
and droperidol (2.5 mg/kg). The animals were then intubated
endotracheally with a 3.5 mm diameter tracheal tube and
mechanically ventilated with a rodent ventilator (SGC,
China). Perfusion-fixation was then performed. The thorax
was opened with a cannula placed in the left ventricle, the
descending thoracic aorta clamped, and the right atrium
open. Perfusion was begun with 500 mL of physiological
phosphate buffer solution (PBS, pH 7.4) at 37°C, followed by
500 mL of 10% buffered formaldehyde under a perfusion
pressure of 120 cm H2O. After perfusion fixation, the whole
brain was removed and immersed in the same fixative
solution.
Nissl staining and cell counting
For Nissl staining, the 4 μm sections were hydrated in 1%
toluidine blue at 50°C for 20 min. After rinsing with
double distilled water, they were dehydrated and mounted
with permount. Normal neurons have relatively big cell
body, rich in cytoplasm, with one or two big round nuclei.
In contrast, damaged cells show shrunken cell body, con-
densed nuclei, dark cytoplasm, and many empty vesicles.
Cell counting was restricted to the external granular lam-
ina layer of the occipital cortex. Six random high power
fields (x400) in each coronary section were chosen bilat-
erally, and the mean number of surviving neurons in the
six views was regarded as the data of each section. Every
third coronary section starting from 3.0 mm posterior to
the optic chiasma was collected and a total of four sections
from each animal were used for quantification. The final
average number of the four sections was regarded as the
data for each sample. And the data were presented as the
number of neurons per high-power field. All the processTable 1 Behavior scores
Category Behavior Score
Finished meal 0
Appetite Left meal unfinished 1
Scarcely ate 2
Active, barking or standing 0
Activity Lying down, will stand and walk with 1
some stimulation
Almost always lying down 2
No deficits 0
Deficits Unable walk due to ataxia or paresis 1
Impossible to walk and stand due to ataxia
and paresis
2was conducted by two pathologists blinded to the
grouping.
TUNEL staining and cell counting
The formalin-fixed tissues were embedded in paraffin and
sectioned at 4 μm thickness with a microtome. The sec-
tions were detected for apoptotic cells by terminal deoxy-
nucleotidyl transferase-mediated dUTPnickend labeling
(TUNEL) method. In situ cell death detection Kit POD
(ISCDD, Boehringer Mannheim, Germany) was used. The
procedures ran according to protocol of the kit and the
other references. Briefly, sections were deparaffinized, rehy-
drated, and washed with distilled water (DW). The tissues
were digested with 20 g/ml proteinase K (Boehringer
Mannheim, Mannheim, Germany) at room temperature
for 15 min. Endogenous peroxidase activity was blocked by
incubation in 0.3% hydrogen peroxide/methanol in PBS at
37°C for 30 min. The sections then were incubated with
terminal deoxynucleotidyl transferase at 37°C for 60 min to
add the dioxigenin-conjugatd dUTP to the 3’-OH ends of
fragmented DNA. Anti-digoxigenin antibody peroxidase
was applied to the sections to detect the labeled nucleo-
tides. The sections were stained with DAB and counter-
stained slightly with hematoxylin. The positive cells were
identified, counted and analyzed under the light micro-
scope by an investigator blinded to the grouping. And
apoptotic neuron counting was also restricted to the external
granular lamina layer of the occipital cortex. Every third cor-
onary section starting from 3.0 mm posterior to the optic
chiasma was collected and a total of 10 sections from each
animal were used for quantification. Six random high power
fields (x400) in each coronary section were chosen bilaterally,
and the mean number of apoptotic neurons in the six views
was regarded as the data of each section. The final average
proportion of apoptotic neurons of the sections was regarded
as the data for each sample and the severity of brain damage
was evaluated by apoptotic index, defined as the average per-
centage of TUNEL-positive neurons.
Determination of the concentrations of MDA
The same part of the occipital cortex was obtained and im-
mediately froze in liquid nitrogen until use. MDA content
was measured by commercial kits (Nanjing Jiancheng Bio-
engineering Institute, Nanjing, China), according to the
methods described by the assay kits. All standards and
samples were run in duplicate. The tissue protein concen-
tration was determined by using a standard commercial
kit (Bio-Rad Laboratories, Hercules, CA, USA).
Western blot analysis
The same part of the occipital cortex was obtained and im-
mediately froze in liquid nitrogen until use. The frozen
brain cortex tissue was mechanically lysed in 20 mM Tris,
pH 7.6, which contains 0.2% SDS, 1% Triton X-100, 1%
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(PMSF), and 0.11 IU/ml aprotinin (all purchased from
Sigma-Aldrich, Inc., St. Luis, MO, USA). Lysates were cen-
trifuged at 12,000×g for 20 min at 4°C. The protein con-
centration was estimated by the Bradford method with the
Nanjing Jiancheng (NJJC) protein assay kit (Nanjing Jian-
cheng Bioengineering Institute, Nanjing, China). The sam-
ples (60 μ g per lane) were separated by 8% SDS-PAGE and
electro-transferred onto a polyvinylidene-difluoride (PVDF)
membrane (Bio-Rad Lab, Hercules, CA, USA). The mem-
brane was blocked with 5% skimmed milk for 2 h at room
temperature, incubated overnight at 4°C with 1:200 rabbit
polyclonal anti- active Caspase-3 primary antibody (Abcam,
UK), and β-actin (diluted 1:6,000 in PBST, Abcam, UK) was
used as a loading control. After the membrane was washed
for 10 min each for six times in PBST, it was incubated in
the appropriate HRP-conjugated secondary antibody
(diluted 1:400 in PBST) for 2 h. The level of Caspase-12
was detected according to the same procedure with 1:200
rabbit polyclonal anti- active Caspase-12 primary antibody
(Abcam, UK) and β-actin(diluted 1:6,000 in PBST, Abcam,
UK). The blotted protein bands were visualized by
enhanced chemiluminescence (ECL) Western blot detection
reagents (Amersham, Arlington Heights, IL, USA) and were
exposed to X-ray film. Developed films were digitized with
an Epson Perfection 2480 scanner (Seiko Corp, Nagano,
Japan). Optical densities were obtained via Glyko Bandscan
software (Glyko, Novato, CA, USA) and the Caspase-3/12
expression levels were normalized to β-actin.
Brain water content measurement
Animals were killed by decapitation and exsanguination.
After removal of the brains, the cerebellum and hemi-
spheres were separated under an operating microscope.
Both cerebral hemispheres were weighed to assess their
wet weight. The hemispheres were dried for 48 hours at
100°C for the determination of the dry weight. Based on
the gravimetric differences, brain water content was
obtained through the following calculation: Brain water
content (%) = (WW-DW)/WW×100, where WW is the
wet weight of double hemispheres (in g) and DW is the dry
weight (in g).
Statistical analysis
All data were presented as mean± SD. SPSS 16.0 was
used for statistical analysis of the data. All data were sub-
jected to one-way ANOVA. Differences between experi-
mental groups were determined by the Fisher’s LSD
post-test. Statistical significance was inferred at P < 0.05.
Results
General observation and clinical evaluation
Among all the experimental groups, no SAH-related death
was observed. None of the rabbits exhibited obviousneurological deficits. The activity scores of these experi-
mental groups did not display a significant difference
among all the experimental groups (P> 0.05, ANOVA,
data not shown). The appetite scores of the rabbits in the
SAH+hydrogen-rich saline group were lower than those
observed in the SAH group, but the difference was not sta-
tistically significant (P> 0.05, data not shown). Moreover,
after the two-time injection of blood, all the SAH models
were qualified: obvious blood clot can be seen around the
brain stem and in the basal cisterns in each of the rabbits
3 days after induced SAH.
Nissl staining
Nissl staining was used to illustrate the morphology change
of the cortical neurons (Figure 1, A1-D2). In the control
group, rare injured neuron was detected (A1, A2). The visual
field was full of clear and intact neurons, without edema
around the cells. However, a significant proportion of neu-
rons in the SAH (B1, B2) and the SAH+saline group(C1,
C2) were damaged, exhibiting extensive degenerative changes
including sparse cell arrangements, loss of integrity, shrunken
cytoplasma, oval or triangular nucleus and swollen cell bod-
ies. In contrast, the severity of neuronal degeneration in the
SAH+hydrogen-rich saline group was evidently alleviated
than that in the SAH or SAH+saline group (D1, D2).
TUNEL staining
As is shown in Figure 1(A3-D4), few TUNEL-positive
apoptotic neurons were found in the cortex of the control
group (A3, A4). In the SAH (B3, B4) and SAH+ saline (C3,
C4) groups, the percentage of apoptotic neuron in the cor-
tex increased substantially in comparison with that in the
control group. However, compared with the SAH or
SAH+ saline group, administration of hydrogen-rich saline
reduced neuronal apoptosis obviously (D3, D4). These
results show that hydrogen-rich saline administration
could alleviate neuronal apoptosis following SAH.
Content of MDA
The content of MDA, which is the primary outcome,
was detected in the control group and the experimental
groups 72 hours after SAH. Compared with the control
group, the content of MDA in SAH and SAH+ saline
group increased apparently. However, hydrogen-rich sa-
line administration dramatically suppressed the produc-
tion of MDA after SAH when compared with that in the
SAH group (Figure 2).
Caspase-12 and caspase-3 activity
The activities of caspase-12 and −3 were measured at
72 h after SAH insult. As shown in Figure 3, SAH
induced evident increase of caspase-12 in the cortex of
SAH and SAH+ saline group, while the level of caspase-
12 decreased markedly in the SAH+hydrogen-rich saline
Figure 1 Nissl and TUNEL staining (A) of cerebral cortex and cell counting (B) at 72 h following SAH. (A) Representative slides of Nissl
staining (A1-D2) and TUNEL staining (A3-D4) at two different magnifications (A1–D1, A3–D3: ×100; A2–D2, A4–D4: ×400). In the control group of
Nissl staining (A1, A2), the neuronal cell outline was clear and the structure was compact with abundant cytoplasm and Nissl body. However,
evident neuronal loss and neuronal degeneration were observed in the SAH group (B1, B2) and SAH+ saline group (C1, C2). Cells arranged
sparsely and the cell outline was fuzzy. The cells with eumorphism were significantly reduced. Compared with SAH or SAH+ saline group,
administration of hydrogen-rich saline substantially increased the proportion of survived neurons (D1, D2). TUNEL staining (A3-D4) showed that
the rabbits in the control group display rare apoptotic neurons in the cortex (A3, A4), while obvious TUNEL positive neurons with intense nuclear
stained as brown could be observed in the SAH group (B3, B4) or SAH+ saline group (C3, C4). In contrast, the proportion of apoptotic neurons
decreased significantly in the SAH+ hydrogen-rich saline group (D3, D4). (B) Cell counts per visual field (×400) found in the slides with Nissl
staining (b1) and TUNEL staining (b2). (b1) #P < 0.05 compared with control group; *P < 0.05 compared with SAH or SAH+ saline group. (b2)
##P < 0.05 compared with control group; **P < 0.05 compared with SAH or SAH+ saline group.
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observed in the cortex of SAH and SAH+ saline group,
and the administration of hydrogen-rich saline decreased
the level of caspase-3 significantly (Figure 4).Brain water content measurement
Brain water content as an indicator of brain edema was
measured at 72 h after SAH. As is shown in Figure 5,
SAH caused significant increase of brain water content
Figure 2 Content of MDA. MDA increased dramatically in the
cortex following SAH. In contrast, hydrogen-rich saline administration
reduced the level of MDA obviously after SAH. Bars represent the
mean± SE. #P < 0.05 compared with control group; *P < 0.05
compared with SAH or SAH+ saline group.
Figure 3 Representative Western blots of caspase-12 activity in
rabbit cortex in the experimental groups. (A) Representative
autoradiogram of the caspase-12 expression by Western blot. (B)
Quantitative analysis of caspase-12 expression detected by Western
blot. As is shown, caspase-12 was significantly increased in the SAH
and SAH+ saline groups compared with that in the control group.
However, caspase-12 expression decreased obviously in the
hydrogen-rich saline group compared with SAH or SAH+ saline
groups. Bars represent the mean± SE. #P < 0.05 compared with
control group; *P < 0.05 compared with SAH or SAH+ saline group.
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ministration of hydrogen-rich saline reduced the brain
water content markedly. These results suggested that
hydrogen-rich saline treatment can significantly attenu-
ate the development of SAH induced brain edema.
Discussion
The main findings of this study are as follows: (1) SAH
induced a significant increase of oxidative stress and evi-
dent brain edema, resulting in obvious brain damage in
the rabbit SAH model; (2) Intraperitoneal administration
of hydrogen-rich saline abated the level of oxidative
stress and brain edema following SAH and, in the mean-
while, alleviated EBI following SAH. These findings sug-
gest that hydrogen-rich saline could alleviate brain injury
via decreasing oxidative stress and brain edema after
SAH. Hence, we conclude that hydrogen-rich saline
could be a potential therapeutic agent for EBI after SAH.
Oxidative stress arises from the strong cellular oxidizing
potential of excess reactive oxygen species (ROS), or free
radicals [28,29]. Plenty of ROS are generated after SAH
and considerable evidences have confirmed that oxidative
stress, which is the focus of this study, is an important me-
diator of brain injury after SAH [12]. Triggered by clot-
derived hemoglobin(Hb), free radicals, including O-2•, H2O2
and •OH, explode subsequently. O-2• is produced by
hemoglobin auto-oxidation and consequent dismutation of
two O-2• forms H2O2, and the latter is the source of highly re-
active •OH in the reaction catalyzed by ferric ion [30]. •OHis the strongest of the oxidant species and reacts
indiscriminately with nucleic acids, lipids and proteins
to produce strong cytotoxic effect [20,31]. The production
of •OH from extravasated hemoglobin [32], mitochondria
disruption [33] and the disruption of the intrinsic antioxi-
dant system [34] have all been proved in experimental or
human SAH. It has been demonstrated that explosion of
free radical species after SAH caused oxidative brain injury
[35], and antioxidative treatments alleviated brain damage
and improved the neurological deficits in a rat model [36].
Lipid peroxidation is mediated by superoxide, such
as •OH, ONOO-, as well as H2O2, resulting in struc-
tural alterations of membranes and functional impair-
ment of cellular components. Malondialdehyde (MDA),
the end product of lipid peroxidation of polyunsaturated
fatty acids in cellular membranes, was identified as a re-
liable marker of oxidative stress, which reflects the
damages of the cell indirectly [37]. In agreement with
Figure 4 Representative Western blots of caspase-3 activity in
rabbit cortex in the experimental groups. (A) The activity of
caspase-3 detected by Western blot in the experimental groups. (B)
Quantitative analysis of caspase-3 expression detected by Western
blot. As is shown, the level of caspase-3 increased substantially in
the SAH and SAH+ saline groups compared with that in the control
group. In contrast, caspase-3 expression decreased significantly in
the SAH+hydrogen-rich saline group compared with that in the
SAH or SAH+ saline group. Bars represent the mean± SE. #P < 0.05
compared with control group; *P < 0.05 compared with SAH or
SAH+ saline group.
Figure 5 Brain water content measurement. As shown, brain
water content increased distinctly in rabbits of SAH group and
SAH+ saline group, and hydrogen-rich saline treatment alleviated
brain edema following SAH significantly. The values are expressed as
mean± SEM (n = 6 per group). #P < 0.05 compared with control
group; *P < 0.05 compared with SAH group.
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study that experimental SAH elevated MDA signifi-
cantly in the brain cortex after SAH. And the adminis-
tration of hydrogen-rich saline decreased MDA
dramatically in comparison with that in the SAH or
SAH+ saline group.
Caspases, or cysteine-aspartic proteases or cysteine-
dependent aspartate-directed proteases are a family of
cysteine proteases that play essential roles in apoptosis
(programmed cell death), necrosis, and inflammation
[39]. Caspase-3 is one member of the caspase family and
it plays a central role in the execution-phase of cell apop-
tosis. It has been reported that the expression of caspase-
3 was intensified in the cortical neurons after SAH [40]
and its inhibition could reduce the neuron loss. Caspase-
12 is recognized to be essential for the endoplastic
reticulum (ER) stress-induced apoptosis. The ER issensitive to alterations in homeostasis from a variety of
stimuli, such as glucose deprivation, perturbation of
calcium homeostasis, and exposure to free radicals.
Excessive stress to the ER results in apoptosis. It has
been demonstrated that during apoptosis induced by
ER stress, caspase-12 is localized to the ER and gets
activated [41]. Caspase-12 is considered as an up-
stream caspase that might activate caspase-3 [42], and
calcium–calpain–caspase-12–caspase-3 cascade was
also suggested to play a role in ER-mediated apoptosis
[43]. In the present study, we analyzed the level of
caspase-3 and caspase-12 in the brain cortex following
SAH. Our data showed that caspase-3 and caspase-12
increased significantly in the SAH and SAH+saline group
but decreased dramatically in the SAH+hydrogen-rich
saline group. These result are in line with the previous study
in brain ischemia [44] and spinal cord injury [24]. There-
fore, we can postulate that ER stress plays a pivotal role in
the neuron death after SAH, and it might be a promising
filed to studying the concrete protective mechanism of
hydrogen in vivo.
Delayed global edema has been shown to be an independ-
ent predictor of death [13]. Cerebral edema, which can lead
to increased intracranial pressure (ICP), brain herniation, ir-
reversible brain damage or even death, is a significant clin-
ical consequence following SAH. Brain edema is generally
classified into cytotoxic or vasogenic edema [45]. Cytotoxic
edema is defined as a cellular swelling with fluid accumulat-
ing within the cell and with the typical instance of astrocyte
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breakdown of the BBB, resulting in the increased fluid accu-
mulation around cells [47]. It has been postulated that
altered expression of water channels aquaporins (AQPs),
development of BBB disruption [48], active substances
derived from blood, as well as secondary events after SAH,
such as raised ICP [49] and hypertension are involved in
the pathogenesis of brain edema. Badaut et al. [50] found a
marked increase in AQP1 and AQP2 protein expression 24
hours after SAH in the human neocortex [51]. One of the
early indications of brain injury after SAH is the alteration
of BBB permeability [48]. In patients with SAH, classic
vasogenic edema, a direct result of BBB breakdown, has
been proved, which has also been shown in experimental
models [52]. In addition, it has been proved that early dys-
function of BBB contributes to brain edema [53] which
expands brain volume and prolongs elevated ICP values
after SAH [54]. Consequently, there is a resultant rise in
ICP, which further reduces cerebral blood flow, leading to
further ischemia [49]. These bring more damage to the
BBB. A vicious circle like this never ends. In this study, we
found that the brain water content increased obviously after
SAH and administration of hydrogen-rich saline abated
brain edema significantly. This accords with what was
reported in the brain trauma model by Ji et al. [55].
It is believed that oxidative stress is closely linked with
brain edema via the discruption of BBB. Oxidative stress is
considered as a major underlying cause of BBB injury.
Oxidative stress-mediated disruption of BBB was shown in
experimental models in vivo [56] or in vitro [57]. It has been
demonstrated that alcohol-induced loss of BBB integrity is
associated with increased production of ROS [58]. In an
in vivo study, Katsu,et al. found that hemoglobin-induced
oxidative stress contributes to matrix metalloproteinase ac-
tivation and BBB dysfunction[59].
Hydrogen is a highly diffusible gas, which can easily pene-
trate the blood – brain barrier by gaseous diffusion. And
hydrogen can also penetrate biomembranes smoothly to
diffuse into the cytosol, nucleus and mitochondria. This is
particularly important, as mitochondria, the primary site of
generation of reactive oxygen species, is notoriously difficult
to target. Ohsawa, et al. [20] reported that hydrogen can
target intracellular sources of reactive oxygen species and
inhibit reperfusion-induced oxidative damage by selectively
scavenging ONOO- and •OH, the strongest of the oxidant
species which reacts indiscriminately with nucleic acids,
lipids and proteins. Therefore, H2 could selectively react
with the •OH to produce water, and did not react with other
ROS that possess physiological functions. In this aspect, H2
is evidently superior to some other antioxidant with strong
reductive reactivity, which can increase mortality, possibly
by affecting essential defensive mechanisms [60]. This is im-
mensely advantageous for medical treatment as the use of
H2 would not bring serious side effects. Up till now,increasing evidence has proved that H2 can be used as an
effective antioxidant therapeutic owing to its ability to de-
crease cytotoxic ROS [22,25,55]. In this study, we find that,
the administration of hydrogen-rich saline decreased oxida-
tive stress (MDA) and caspase-3/12 distinctly, which is in
accordance with the previous reports. Meanwhile,
hydrogen-rich saline abates the brain edema induced by
SAH significantly. Correspondingly, the brain injury was
alleviated in the SAH+hydrogen-rich saline group, and all
the results in the present study were basically in accordance
with the previous related reports [25,61].
With regard to the animal model, till now, a number of
SAH models have been applied, and three of them are com-
monly seen: the intracranial endovascular perforation model,
the blood injection into the cisterna magna model, and the
blood injection into the prechiasmatic cistern model. How-
ever, controversy exists regarding which method of selection
is appropriate for different animals and the drawbacks of
each of the models [62]. Blood injection into the cisterna
magna is the most frequently applied experimental SAH
method in rabbits and both the one- and two-hemorrhage
models are used to make rabbit SAH model. In our previous
study, it was proved that the two-hemorrhage model in rab-
bits is more appropriate than the one-hemorrhage model for
the research on SAH [63]. Consequently, the two-
hemorrhage rabbit SAH model was used in the present
study. However, like other models, the two-hemorrhage
rabbit SAH model could not imitate the clinical SAH ideally
as well. None of the rabbits died till 72 hours following SAH
and evident neurological deficits could rarely be observed.
Admittedly, there are many differences between the two-
hemorrhage rabbit SAH model in this study and the clinical
SAH. Hence, objectively, the SAH model in this study still
needs further improvement, though obvious brain injury
was found following the two-time SAH.
In addition, there was no statistically significant difference
in clinical evaluation of the rabbits among the groups in this
study, while evident neurological improvement was
observed in the hydrogen treated hypoxia–ischemia rat
model [25]. In effect, there are fewer behavior tests devised
for the rabbit SAH model, and the differences in model and
the scoring system could bring about inconsistent findings.
As a result, we extrapolate that, to some extent, the neuro-
behavior evaluation system in the present experiment is not
sensitive enough to discriminate the neurological difference
in different groups. More sensitive neurobehavior tests for
rabbit are necessitated in order to render the results more
accurate and scientific, with which Hyojin Jeon et al. share
the same opinion [64].
Conclusion
Here, we demonstrated that hydrogen-rich saline could
alleviate early brain injury via suppressing oxidative stress
and brain edema after SAH. Hence, it may be a potential
Zhuang et al. BMC Neuroscience 2012, 13:47 Page 9 of 10
http://www.biomedcentral.com/1471-2202/13/47therapeutic agent for early brain injury following SAH.
However, the molecular mechanisms of hydrogen under-
lying its marked effects remain elusive, and there is limited
information on hydrogen related pathway in vivo. There-
fore, much work remains to be conducted to elucidate this
novel area, including the concrete mechanism and the out-
come in the long term.
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